Expression of leukotriene B₄ receptor-1 on CD8⁺ T cells is required for their migration into tumors to elicit effective antitumor immunity.
Expression of leukotriene B₄ receptor-1 on CD8⁺ T cells is required for their migration into tumors to elicit effective antitumor immunity.
复制标题
DOI:
10.4049/jimmunol.1300967
复制
发表时间:
2013-09-15
期刊:
影响因子:
--
通讯作者:
Haribabu B
中科院分区:
文献类型:
--
作者:
Sharma RK;Chheda Z;Jala VR;Haribabu B
Leukotriene B4 (LTB4) receptor, BLT1 is expressed on variety of immune cells and has been implicated as a mediator of diverse inflammatory diseases. However, whether biological responses initiated via this receptor generate tumor promoting inflammation or anti-tumor immunity remains unexplored. In this study, we investigated the role of BLT1 in antitumor immunity using syngeneic TC-1 cervical cancer model and observed accelerated tumor growth and reduced survival in BLT1−/− mice compared to BLT1+/+ mice. Analysis of the tumor infiltrates by flow cytometry and confocal microscopy revealed a significant decrease in effector immune cells, most notably CD8+-T cells and NK cells in the tumors of the BLT1−/− mice. Gene expression profiling confirmed the dramatic decrease of IFN-γ, granzyme-B and IL-2 in tumors growing in BLT1−/− mice. Furthermore, depletion of CD8+ T cells enhanced the tumor growth in BLT1+/+ but not in BLT1−/− mice. However, similar levels of antigen dependent CD8+ T cell mediated killing activity were observed in spleens of BLT1+/+ and BLT1−/− mice. Adoptive transfer of CD8+ T cells from tumor bearing BLT1+/+ but not BLT1−/− mice significantly reduced tumor growth and increased the survival of Rag2−/− mice. While the homeostatic proliferation and expression profiles of other chemokine receptors of adoptively transferred BLT1+/+ and BLT1−/− CD8+ T cells appears to be similar, BLT1+/+ T-lymphocytes entered the tumors in greater numbers. These results suggest that BLT1 expression on CD8+ T cells plays an important role in their trafficking to tumors.
登录
查看更多内容
DOI:
10.1084/jem.192.3.433
发表时间:
2000-08-07
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Haribabu B;Verghese MW;Steeber DA;Sellars DD;Bock CB;Snyderman R
通讯作者:
Snyderman R
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
4.4
作者:
Miyahara, N;Takeda, K;Gelfand, EW
通讯作者:
Gelfand, EW
影响因子:
20.3
作者:
Fan, ZS;Yu, P;Fu, YX
通讯作者:
Fu, YX
DOI:
10.1152/ajplung.00212.2005
发表时间:
2006-01-01
影响因子:
4.9
作者:
Medoff, BD;Tager, AM;Luster, AD
通讯作者:
Luster, AD